Last Updated : October 9, 2018
Details
FilesGeneric Name:
Tiotropium / olodaterol
Project Status:
Complete
Therapeutic Area:
Chronic obstructive pulmonary disease
Manufacturer:
Boehringer Ingelheim (Canada) Ltd.
Call for patient/clinician input open:
Brand Name:
Inspiolto Respimat
Project Line:
Reimbursement Review
Project Number:
SR0436-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC
Submission Type:
New
Indications:
Chronic Obstructive Pulmonary Disease (COPD)
Recommendation Type:
List with criteria/condition
Final Recommendation:
Files
Last Updated : October 9, 2018